David Golovsky

Robert Bosch (Australia) — Australia

Medicine · Health Sciences

19h-index1.8kcitations41works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(11), Prostate Cancer Treatment and Research(11), Bladder and Urothelial Cancer Treatments(4), Spine and Intervertebral Disc Pathology(3), Epigenetics and DNA Methylation(3)

Publications41 total

Early infant male circumcision: Systematic review, risk-benefit analysis, and progress in policy
World Journal of Clinical Pediatrics·2017· 73 citedOpen Access
POS-03.04: Robotic pyeloplasty using a 4 arm technique
Urology·2007
MP-11.18: Is there evidence of a continued stage migration in the PSA screening era in an Australian population?
Urology·2007
POS-03.100: Successful implementation of a robotic prostatectomy programme: a no-complication learning curve
Urology·2007
Aberrant Neuropeptide Y and Macrophage Inhibitory Cytokine-1 Expression Are Early Events in Prostate Cancer Development and Are Associated with Poor Prognosis
Cancer Epidemiology Biomarkers & Prevention·2006· 67 citedOpen Access
12 
Outcomes of radical prostatectomies and HDR brachytherapy in patients with intermediate and high risk prostate cancer
British Journal of Urology·2006
1022 Prediction of adverse radical prostatectomy pathology in patients with single positive biopsy Gleason 6 prostate cancer
European Urology Supplements·2005
Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer
International Journal of Cancer·2004· 58 citedOpen Access
1079: Neuropeptide Y Expression is increased in the Progression from Benign to Malignant Prostate Epithelium and Predicts Outcome after Radical Prostatectomy
The Journal of Urology·2004Open Access
173 Solitary positive apical margin a treatment dilemma
European Urology Supplements·2004
Membranous Expression of Secreted Frizzled-Related Protein 4 Predicts for Good Prognosis in Localized Prostate Cancer and Inhibits PC3 Cellular Proliferation <b> <i>in Vitro</i> </b>
Clinical Cancer Research·2004· 79 citedOpen Access
Loss of BMP2, Smad8, and Smad4 expression in prostate cancer progression
The Prostate·2003· 120 cited
Prognostic significance of Gleason pattern in patients with Gleason score 7 prostate carcinoma
Cancer·2003· 92 citedOpen Access
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer
Oncogene·2003· 115 cited
Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy
Cancer·2003· 90 citedOpen Access
Prognostic Significance of Pathologic Features in Localized Prostate Cancer Treated With Radical Prostatectomy: Implications for Staging Systems and Predictive Models
Journal of Clinical Oncology·2001· 76 cited
Frequent loss of estrogen receptor-beta expression in prostate cancer.
PubMed·2001· 304 cited
Up to date urology
The Medical Journal of Australia·2001
Overexpression of the cell cycle inhibitor p16INK4A in high-grade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients.
PubMed·2001· 81 cited
Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer.
PubMed·2001· 208 cited
page 1 of 3Next →

Frequent Co-authors

Phillip D. Stricker(20), Susan M. Henshall(14), Phillip Brenner(14), Raji Kooner(14), John J. Grygiel(12), Robert L. Sutherland(12), Gordon O’Neill(11), Warick Delprado(10), Lisa G. Horvath(8), Jennifer Turner(8), David I. Quinn(7), Krishan Rasiah(7), James G. Kench(6), Darren R. Head(4), Cheok Soon Lee(4), Kimberley Pryor(4), Ronald Penny(4), Pamela J. Russell(3), Ruban Thanigasalam(3), John F. Finlayson(2)